AstraZeneca PLC
1454,00
23-декабря-24 11:29:54
15 мин. задержка
Акции
+21,00
+1,47%
Сегодняшний диапазон
1439,00 - 1458,00
ISIN
N/A
Источник
NASD.OMX SE
- Котировки
- Графики
Новости
- Статистика
-
22 дек 2024 06:16:51 Источник NASDAQ US Markets
-
3 Unstoppable Stocks to Buy Right Now
15 дек 2024 06:33:05 Источник NASDAQ US Markets
-
March 2025 Options Now Available For AstraZeneca (AZN)
06 дек 2024 11:01:12 Источник NASDAQ US Markets
-
AZN : TROPION Analysis Reveals Datopotamab Deruxtecan Efficacy In Advanced EGFR-Mutated Lung Cancer
05 дек 2024 22:31:29 Источник NASDAQ US Markets
-
FDA Approves AstraZeneca's Imfinzi For Limited-Stage Small Cell Lung Cancer
04 дек 2024 21:59:20 Источник NASDAQ US Markets
-
AstraZeneca Names A MSK Leader To Global Cancer Post
25 ноя 2024 11:17:34 Источник Forbes - World
-
Lunit Collaborates With AstraZeneca To Develop AI-powered Digital Pathology Solutions
18 ноя 2024 13:17:39 Источник NASDAQ US Markets
-
Is AstraZeneca a Buy as It Eyes the Weight Loss Market?
14 ноя 2024 07:43:11 Источник NASDAQ US Markets
-
AstraZeneca Plc (AZN) Q3 2024 Earnings Call Transcript
12 ноя 2024 17:04:51 Источник NASDAQ US Markets
-
AstraZeneca Q3 Net Income Rises; Upgrades 2024 Guidance
12 ноя 2024 03:02:49 Источник NASDAQ US Markets
-
AstraZeneca To Invest $3.5 Bln In US To Expand R&D And Manufacturing
12 ноя 2024 03:02:49 Источник NASDAQ US Markets
-
AstraZeneca : Wainzua Recommended By CHMP For EU Approval In Hereditary Transthyretin Amyloidosis
21 окт 2024 03:00:49 Источник NASDAQ US Markets
-
AstraZeneca Inks Agreement to Boost Cardiovascular Pipeline
08 окт 2024 14:20:34 Источник NASDAQ Stocks
-
Arcus Announces Clinical Trial Collaboration With AstraZeneca To Evaluate Casdatifan
02 окт 2024 17:15:33 Источник NASDAQ US Markets
-
AstraZeneca Becomes Oversold (AZN)
24 сен 2024 18:47:41 Источник NASDAQ US Markets
-
AstraZeneca Becomes Oversold (AZN)
24 сен 2024 18:45:01 Источник NASDAQ Stocks
-
CHMP Endorses AstraZeneca's Fasenra in Rare Autoimmune Disease
24 сен 2024 13:14:18 Источник NASDAQ Stocks
-
AstraZeneca: TROPION-Breast01 Phase III Trial Fails To Achieve Statistical Significance
23 сен 2024 03:29:23 Источник NASDAQ US Markets
-
AZN : IMFINZI Regimen Reduces Death Risk By 25% In Late-Stage Muscle-Invasive Bladder Cancer Trial
15 сен 2024 13:57:59 Источник NASDAQ US Markets
-
SOPHiA Genetics, AstraZeneca Team Up To Expand Liquid Biopsy Testing To 20 New Locations Globally
10 сен 2024 11:30:45 Источник NASDAQ US Markets
- <<
- <
- 1
- >